It’s been a pretty exciting week on UK share markets. Signs of a breakthrough on a Covid-19 vaccine reported on Monday have driven the FTSE 100 to five-month highs above 6,300 points. Meanwhile, the FTSE 250 has jumped 1,000 points since on Friday. And it’s now sitting at levels not seen since early March.
The bulls are clearly in charge right now. But this improved enthusiasm across UK share indices hasn’t benefitted all stocks. There are plenty of top stocks that have been completely overlooked by Mr Market. A number have even reversed since news of Pfizer and BioNTech’s vaccine broke.
2 great UK shares I’d buy in my ISA
What’s more, a large number of these unloved stocks provide — in my opinion, at least — the sort of value that’s too good to overlook right now. Here are two quality UK shares I’m thinking of adding to my own Stocks and Shares ISA today:
- dotDigital Group’s (LSE: DOTD) share price crashed to six-week lows after news of the Covid-19 vaccine broke. Presumably, investors thought that demand for the company’s services will suffer in the event of no further lockdowns. DotDigital’s technology allows companies to provide personalised shopping experiences to their online customers. This may be true, but it doesn’t mean the e-commerce segment won’t continue growing at a blistering rate. dotDigital trades on a forward price-to-earnings (P/E) ratio of 40 times, but I still think it’s a brilliant dip buy despite this high rating. As I say, all the data suggests online shopping volumes will continue rocketing. And secondly, this UK share has had a knack of beating broker forecasts recently. Just last month, it said it “expects to deliver a greater rate of revenue growth this financial year versus current consensus expectations” after a strong July-September quarter. Trading during its first fiscal quarter was enhanced by new customer wins, growth among existing customers, and a significant take up of non-email channels. I reckon a significant re-rating could be just around the corner.
- CVS Group’s (LSE: CVSG) a stock I already own in my Stocks and Shares ISA. While its share price has carried higher since the start of the week, a forward price-to-earnings growth (PEG) ratio of 0.8 suggests the vetcare provider remains undervalued by the market. And, at current prices, I’m thinking of buying some more. The British animalcare market is growing at a brilliant rate. According to Statista, it was worth £5.2bn last year, compared to just £1.4bn in 2005. And this UK share — which has 480 veterinary surgeries across the UK, Ireland and the Netherlands, as well as diagnostics centres and pet crematoria — is in a great shape to ride this trend. It’s why City analysts reckon CVS Group’s annual earnings will rocket 30% this fiscal year alone. I plan to hold this UK share in my ISA for years to come.
